The role of the gut microbiome and microbial metabolism in mediating opioid-induced changes in the epigenome
- PMID: 37670983
- PMCID: PMC10475585
- DOI: 10.3389/fmicb.2023.1233194
The role of the gut microbiome and microbial metabolism in mediating opioid-induced changes in the epigenome
Abstract
The current opioid pandemic is a major public health crisis in the United States, affecting millions of people and imposing significant health and socioeconomic burdens. Preclinical and clinical research over the past few decades has delineated certain molecular mechanisms and identified various genetic, epigenetic, and environmental factors responsible for the pathophysiology and comorbidities associated with opioid use. Opioid use-induced epigenetic modifications have been identified as one of the important factors that mediate genetic changes in brain regions that control reward and drug-seeking behavior and are also implicated in the development of tolerance. Recently, it has been shown that opioid use results in microbial dysbiosis, leading to gut barrier disruption, which drives systemic inflammation, impacting the perception of pain, the development of analgesic tolerance, and behavioral outcomes. In this review, we highlight the potential role of microbiota and microbial metabolites in mediating the epigenetic modifications induced by opioid use.
Keywords: epigenetic; metabolites; microbial metabolism; microbiome; opioids.
Copyright © 2023 Kolli and Roy.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use.Gut Microbes. 2023 Dec;15(2):2246184. doi: 10.1080/19490976.2023.2246184. Gut Microbes. 2023. PMID: 37610102 Free PMC article.
-
The bidirectional relationship between opioids and the gut microbiome: Implications for opioid tolerance and clinical interventions.Int Immunopharmacol. 2023 Dec;125(Pt A):111142. doi: 10.1016/j.intimp.2023.111142. Epub 2023 Oct 31. Int Immunopharmacol. 2023. PMID: 37918085 Review.
-
Pain and Opioid-Induced Gut Microbial Dysbiosis.Biomedicines. 2022 Jul 28;10(8):1815. doi: 10.3390/biomedicines10081815. Biomedicines. 2022. PMID: 36009361 Free PMC article. Review.
-
Epigenetics in depression and gut-brain axis: A molecular crosstalk.Front Aging Neurosci. 2022 Dec 13;14:1048333. doi: 10.3389/fnagi.2022.1048333. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36583185 Free PMC article. Review.
-
The Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes.Front Genet. 2020 Jan 15;10:1329. doi: 10.3389/fgene.2019.01329. eCollection 2019. Front Genet. 2020. PMID: 32010189 Free PMC article. Review.
Cited by
-
Pharmacogenomic and Pharmacomicrobiomic Aspects of Drugs of Abuse.Genes (Basel). 2025 Mar 30;16(4):403. doi: 10.3390/genes16040403. Genes (Basel). 2025. PMID: 40282363 Free PMC article. Review.
-
Systemic inflammation is associated with gut microbiota diversity in post-stroke patients.Eur Geriatr Med. 2025 Apr;16(2):689-699. doi: 10.1007/s41999-025-01159-2. Epub 2025 Feb 11. Eur Geriatr Med. 2025. PMID: 39934474
-
Diversity and host interaction of the gut microbiota in specific pathogen-free pigs.Front Microbiol. 2024 May 10;15:1402807. doi: 10.3389/fmicb.2024.1402807. eCollection 2024. Front Microbiol. 2024. PMID: 38800748 Free PMC article.
-
Long access heroin self-administration significantly alters gut microbiome composition and structure.Front Psychiatry. 2024 Feb 27;15:1369783. doi: 10.3389/fpsyt.2024.1369783. eCollection 2024. Front Psychiatry. 2024. PMID: 38476614 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous